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Aim of study
This paper describes the development of a community pharmacy CPD program designed to facilitate quality improvement measures for cardiovascular risk reduction among 
patients being treated for hypertension.
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Background
Hypertension (HT) is a typical area where changing pharmacy practice through focussed continuing professional development (CPD) activities may help to address evidence–
treatment (ET) gaps. Activities include facilitating more targeted counselling and other interventions. The project ‘Controlling Hypertension through Innovation in Primary Care’
(CHIP C) project seeks to develop a CPD model which promotes active and sustainable implementation of  community pharmacy interventions following CPD.
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1.  ORIENTATION
Promote general awareness of the idea, stimulate 
interest and involvement
• Engage pharmacists, CVD organisations, other stakeholders
• Dialogue about evidence treatment (ET) gaps and 
pharmacists’ role
2.  INSIGHT
Provide insights into current hypertension (HT) 
management and the need to change
• Literature review to identify ET gaps
• Patient survey to confirm relevance to practice
• Practice audit to document where current performance 
can improve
3. ACCEPTANCE
Develop positive attitudes and intentions towards change
• Involve ‘champions’ (National Stroke Foundation, Heart 
Foundation as advocates)
• Continue dialogue about ET gaps
• Promote ease of integration, CPD credit points
B. Evidence-based CPD materials development
4. CHANGE
Promote actual adoption into practice, confirm the benefit
• Baseline training and resources
• Web-based educational materials and clinical resources (see 
part B)
• Repeat patient survey after intervention
5. MAINTENANCE 
Integrate and embed new practices
• Feedback on practice audits
• Plan, Do, Study, Act Cycles 4
• Adopt as core, ongoing CPD activity
• Online discussion to share innovation with other pharmacists
Content should address:
•Attitudes to change in practice (e.g. 
importance)
•Subjective norms
•Perceived self-efficacy
Literature search:
Identify ET gaps, 
evidence for 
interventions
Focus clinical interventions in the 
following areas:
• Patient education
• Medicines adherence
• Intensification of treatment
• Antiplatelet use
• Lifestyle modification
• Smoking cessation
Delivery methods should encourage:
•Active involvement by pharmacist 
•Problem-based learning
•Building on experience
•Self-directed learning
•Feedback from peers and researcher
•Self-reflection by pharmacist
THEORYPRINCIPLE IMPLICATIONS
Promote evidence-based 
clinical interventions
Facilitate  practice change 
among pharmacists 
Theory of 
Planned 
Behaviour 2
Adult learning 
principles3
Use effective methods 
to deliver educational 
materials
